The PE Ratio as of September 2024 (TTM) for ORIC Pharmaceuticals, Inc. (ORIC) is -5.48

According to ORIC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.48. This represents a change of 4.47% compared to the average of -5.25 of the last 4 quarters.

ORIC Pharmaceuticals, Inc. (ORIC) Historical PE Ratio (quarterly & annually)

How has ORIC PE Ratio performed in the past?

The mean historical PE Ratio of ORIC Pharmaceuticals, Inc. over the last ten years is -15.77. The current -5.48 PE Ratio has changed 3.38% with respect to the historical average. Over the past ten years (40 quarters), ORIC's PE Ratio was at its highest in in the September 2022 quarter at -1.32. The PE Ratio was at its lowest in in the June 2019 quarter at -20.67.

ORIC Pharmaceuticals, Inc. (ORIC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ORIC Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ORIC Pharmaceuticals, Inc. (ORIC) Average PE Ratio

How has ORIC PE Ratio performed in the past?

The current PE Ratio of ORIC Pharmaceuticals, Inc. (ORIC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ORIC Pharmaceuticals, Inc. (ORIC) PE Ratio vs. Peers

How is ORIC’s PE Ratio compared to its peers?

ORIC Pharmaceuticals, Inc.’s PE Ratio is less than Seer, Inc. (-1.29), less than Anebulo Pharmaceuticals, Inc. (-4.99), greater than Cullinan Oncology, Inc. (-6.96), less than C4 Therapeutics, Inc. (-3.44), less than Molecular Partners AG (0), less than Mineralys Therapeutics, Inc. (-2.67), less than AN2 Therapeutics, Inc. (-4.63), less than Pharvaris N.V. (-0.47), greater than PepGen Inc. (-8.20), less than Werewolf Therapeutics, Inc. (-3.22), less than Edgewise Therapeutics, Inc. (-1.64), greater than Decibel Therapeutics, Inc. (-14.14), less than Celcuity Inc. (-1.94), greater than Theseus Pharmaceuticals, Inc. (-7.01), less than PMV Pharmaceuticals, Inc. (-3.19), less than Enliven Therapeutics, Inc. (-1.58), greater than Immuneering Corporation (-12.44), less than null (-0.62),

Build a custom stock screener for ORIC Pharmaceuticals, Inc. (ORIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ORIC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ORIC Pharmaceuticals, Inc. (ORIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ORIC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.